AZD-9291(Mesylate) is used to treat patients with advanced non-small cell lung cancer with epidermal growth factor receptor (EGFR) T790M mutations or resistance to other EGFR inhibitors. AZD-9291 (Mesylate) is active against exon 19 deletions, exon 21 mutations, and also the exon 20 T790M mutations. It is preferentially selective for mutated EGFR, and therefore toxicity at therapeutic doses is lower than for first- and second-generation agents. Notably, AZD-9291 (Mesylate) is able to cross the blood-brain barrier, making it active against disease in the CNS.
|Any single impurity||≤0.1%||0.04%|
|Residue Solvents||Ethyl acetate≤0.5%||0.098%|
|Package details:||1kg/foil bag;25kg/drum|
Guaranteed the purity
High quality & competitive price
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!